Clinical trial
A Double Blind, Randomized, Placebo Controlled, Parallel Group Study of Sativex in the Treatment of Subjects With Pain Due to Diabetic Neuropathy
NCT00710424 is registered in ClinicalTrials.gov with Jazz Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double Blind, Randomized, Placebo Controlled, Parallel Group Study of Sativex in the Treatment of Subjects With Pain Due to Diabetic Neuropathy
- Lead sponsor
- Jazz Pharmaceuticals
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- June 30, 2006
- Enrollment
- 297 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic neuropathy, pain